483
Pfizer Inc.Pfizer Inc. – FDA 483, Sep 30, 2014
Record Details
An FDA inspection of Pfizer Inc. Groton Laboratories, a nonclinical laboratory, identified one observation. The observation noted that the study director failed to ensure that a protocol amendment for a toxicity study was approved and followed before the changes had already occurred. This indicates a procedural lapse in adhering to study protocols.
- Person
View Company Profile
ID · 604fcf10-3f8c-4f4c-b790-320e59c6dd2a
Other documents for Pfizer Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.